Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2-NBDG: Fluorescent Glucose Analog for Quantitative Gluco...

    2025-12-19

    2-NBDG: Fluorescent Glucose Analog for Quantitative Glucose Uptake Assays

    Executive Summary: 2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) is a fluorescent glucose analog that quantitatively tracks cellular glucose uptake in live cells and tissues. It enters cells via glucose transporters and is phosphorylated by hexokinase, leading to intracellular retention and fluorescence (see APExBIO). 2-NBDG is soluble in water (≥17.1 mg/mL with ultrasound) and ethanol (≥2.93 mg/mL with warming), but insoluble in DMSO. The analog is used in diabetes, tumor, and neurological disease models, as well as in diverse cell types (e.g., HepG2, MCF-7, L6, astrocytes), supporting reproducible and sensitive glucose uptake assays (Hong et al., 2025, DOI). Rapid uptake kinetics and stable fluorescence enable quantitative analysis by flow cytometry, fluorescence microscopy, or microplate assays.

    Biological Rationale

    Glucose uptake is a central event in cellular metabolism, disease progression, and metabolic research. Quantitative monitoring of this process is critical for studying disorders such as diabetes mellitus, cancer, and epilepsy [1]. Traditional radiolabeled tracers pose safety and disposal challenges. 2-NBDG, a fluorescent glucose analog, enables high-sensitivity, non-radioactive measurement of glucose transport and metabolism. Its use extends across cell culture models (e.g., HepG2, MCF-7, L6, astrocytes) and animal models (e.g., Sprague–Dawley rats for epilepsy localization) [2]. The analog supports dynamic, real-time monitoring using established laboratory platforms, facilitating both basic and translational research.

    Mechanism of Action of 2-NBDG

    2-NBDG is structurally derived from 2-deoxyglucose, modified by conjugation with a 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) fluorophore. It mimics glucose in cellular uptake, utilizing glucose transporter proteins (primarily GLUTs) on the plasma membrane [1]. Upon entry, 2-NBDG is phosphorylated by hexokinase, trapping the labeled molecule inside the cell due to the negative charge of the phosphate group (see product details). The NBD group confers strong green fluorescence (excitation/emission: ~465/540 nm), detectable by flow cytometry, fluorescence microscopy, or microplate readers. Intracellular retention is stable for at least 30–60 minutes under standard assay conditions, allowing for reproducible endpoint or kinetic measurements. The specificity and intensity of fluorescence correlate directly with cellular glucose uptake rates.

    Evidence & Benchmarks

    • 2-NBDG enables quantitative assessment of glucose uptake in live HepG2, L6, MCF-7, and astrocyte cultures, with rapid uptake observed in the first 1–5 minutes and plateauing by 20–30 minutes in MCF-7 cells (DOI:10.1186/s12986-025-01048-2).
    • In mouse models of diabetes and metabolic disease, 2-NBDG fluorescence accurately reports hepatic and islet glucose uptake, facilitating evaluation of interventions such as quercetin (DOI:10.1186/s12986-025-01048-2).
    • Stock solutions of 2-NBDG remain stable for several months at <-20°C, but long-term storage of diluted solutions is not recommended due to fluorescence decay (APExBIO).
    • Typical working concentrations are 10 μM for 10 minutes at 37°C, with robust signal-to-noise in both flow cytometry and microscopy platforms (internal guide).
    • 2-NBDG has demonstrated utility in in vivo animal imaging, including localization of epileptic foci in Sprague–Dawley rats (DOI:10.1186/s12986-025-01048-2).

    This article extends previous internal guides, such as "2-NBDG: Fluorescent Glucose Analog for Quantitative Gluco...", by integrating recent disease model findings and up-to-date preparation protocols.

    Applications, Limits & Misconceptions

    2-NBDG is widely applied in metabolic research, including:

    • Diabetes research: Quantitative measurement of glucose uptake in hepatocytes, β-cells, and adipocytes (DOI).
    • Tumor xenograft glucose metabolism: Tracking altered metabolic flux in cancer cells (e.g., MCF-7, HepG2).
    • Epilepsy and neurological models: Localization of metabolic activity in brain tissues.
    • Drug screening: Assessment of compound effects (e.g., quercetin) on glucose uptake via the PI3K/AKT/GSK3β pathway.

    Compared to "Enhancing Glucose Uptake Assays: Practical Guidance with ...", this dossier adds evidence on 2-NBDG's performance in in vivo models and highlights best practices for solution preparation and storage.

    Common Pitfalls or Misconceptions

    • 2-NBDG is not a substrate for glycolytic metabolism beyond phosphorylation, preventing full metabolic flux analysis.
    • Insolubility in DMSO limits its use in organic-based delivery systems; only aqueous or ethanol-based preparations are recommended (APExBIO).
    • Long-term storage of working solutions (>24 hours) leads to fluorescence decay and unreliable results.
    • High background fluorescence may occur if wash steps are inadequate, particularly in adherent cell assays.
    • Not suitable as a substitute for radiolabeled 2-deoxyglucose in metabolic flux analysis involving downstream glycolytic intermediates.

    This section clarifies boundaries not fully covered in guides like "Solving Glucose Uptake Assay Challenges with 2-NBDG (SKU ...)", by emphasizing limitations in metabolic pathway tracing.

    Workflow Integration & Parameters

    2-NBDG is supplied by APExBIO as a crystalline solid (SKU B6035). For optimal solubilization, dissolve at ≥17.1 mg/mL in water with ultrasonic agitation, or at ≥2.93 mg/mL in ethanol with gentle warming (37°C) and ultrasound. Do not use DMSO. Typical experimental conditions are 10 μM for 10 minutes at 37°C. For higher concentrations, extended ultrasonic treatment is recommended. Stock solutions should be aliquoted and stored below -20°C. Avoid repeated freeze-thaw cycles and prepare working solutions fresh before use. Analytical platforms include:

    • Flow cytometry: Rapid, high-throughput quantitation of single-cell glucose uptake.
    • Fluorescence microscopy: Visualizes spatial uptake patterns, especially in adherent cells or tissues.
    • Microplate reader assays: Enables kinetic or endpoint measurements in multiwell formats.

    For troubleshooting, see "Solving Glucose Uptake Assay Challenges with 2-NBDG (SKU ...)", which provides actionable guidance on reproducibility and workflow optimization.

    Conclusion & Outlook

    2-NBDG (APExBIO, SKU B6035) is a robust, high-sensitivity fluorescent glucose analog for quantitative cellular glucose uptake measurement. It facilitates research in diabetes, cancer, and neurological disorders, with validated protocols for solution preparation, storage, and multi-platform analysis. Awareness of its biochemical boundaries and workflow requirements is essential for reliable data. Ongoing research, including disease model applications, continues to expand the utility of 2-NBDG in metabolic studies (Hong et al., 2025).